HALO ▲ +0.8% - Halozyme Therapeutics, Inc. $HALO - Halozyme Therapeutics, Inc. Announces Proposed Offering of $1.05 Billion of Convertible Senior Notes due 2033 Halozyme Therapeutics announced a proposed offering of $1.05 billion in convertible senior notes due 2033, a financing move that lifted shares 0.8% today. The company's decision to raise capital through convertible debt—which can be exchanged for stock—was apparently received positively by investors. 16-SEP-2026 04:33 PM ET